IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.880
-0.010 (-0.53%)
Aug 8, 2025, 2:37 PM - Market open

Paramount Global Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
1246112466184-
Upgrade
Market Cap Growth
-36.99%-51.06%86.88%-64.06%--
Upgrade
Enterprise Value
89-18-39-82268-
Upgrade
Last Close Price
1.890.921.882.306.40-
Upgrade
PB Ratio
4.711.290.930.480.87-
Upgrade
P/TBV Ratio
4.711.290.930.480.87-
Upgrade
Debt / Equity Ratio
0.070.040.020.02--
Upgrade
Quick Ratio
2.083.149.1813.5020.731.61
Upgrade
Current Ratio
2.323.339.3713.8821.521.85
Upgrade
Return on Equity (ROE)
-138.78%-106.00%-63.29%-40.74%-63.28%-2127.56%
Upgrade
Return on Assets (ROA)
-70.13%-54.47%-37.78%-23.87%-22.61%-84.11%
Upgrade
Return on Capital (ROIC)
-83.55%-64.45%-41.22%-25.25%-24.03%-129.47%
Upgrade
Earnings Yield
-79.07%-157.55%-69.50%-107.82%-36.81%-
Upgrade
FCF Yield
-64.69%-135.94%-58.18%-91.16%-22.12%-
Upgrade
Buyback Yield / Dilution
-24.76%-51.31%-51.10%-564.62%-2346.74%-
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q